These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17201669)

  • 21. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection.
    Austin BA; James C; Silverman RH; Carr DJ
    J Immunol; 2005 Jul; 175(2):1100-6. PubMed ID: 16002711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
    Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT
    J Leukoc Biol; 2006 Dec; 80(6):1405-15. PubMed ID: 16997857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection.
    Carr DJ; Campbell IL
    J Neurovirol; 1999 Oct; 5(5):449-57. PubMed ID: 10568881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.
    Leib DA; Harrison TE; Laslo KM; Machalek MA; Moorman NJ; Virgin HW
    J Exp Med; 1999 Feb; 189(4):663-72. PubMed ID: 9989981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection.
    Minami M; Kita M; Yan XQ; Yamamoto T; Iida T; Sekikawa K; Iwakura Y; Imanishi J
    J Interferon Cytokine Res; 2002 Jun; 22(6):671-6. PubMed ID: 12162877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection.
    Carr DJ; Chodosh J; Ash J; Lane TE
    J Virol; 2003 Sep; 77(18):10037-46. PubMed ID: 12941914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to ocular herpes simplex virus type 1 infection in IL-12 transgenic mice.
    Al-Khatib K; Campbell IL; Carr DJ
    J Neuroimmunol; 2002 Nov; 132(1-2):41-8. PubMed ID: 12417432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression, Inducers and Cellular Sources of the Chemokine MIG (CXCL 9), During Primary Herpes Simplex Virus Type-1 Infection of the Cornea.
    Molesworth-Kenyon SJ; Milam A; Rockette A; Troupe A; Oakes JE; Lausch RN
    Curr Eye Res; 2015; 40(8):800-8. PubMed ID: 25207638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.
    Carr DJ; Noisakran S
    J Virol; 2002 Sep; 76(18):9398-406. PubMed ID: 12186922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL9 compensates for the absence of CXCL10 during recurrent Herpetic stromal keratitis.
    Tajfirouz D; West DM; Yin XT; Potter CA; Klein R; Stuart PM
    Virology; 2017 Jun; 506():7-13. PubMed ID: 28282568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice.
    Miller JK; Laycock KA; Umphress JA; Hook KK; Stuart PM; Pepose JS
    Cornea; 1996 Sep; 15(5):497-504. PubMed ID: 8862927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL1-deficient mice are highly sensitive to pseudomonas aeruginosa but not herpes simplex virus type 1 corneal infection.
    Bryant-Hudson KM; Carr DJ
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6785-92. PubMed ID: 22952118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokines and ocular pathology caused by corneal infection with herpes simplex virus.
    Kumaraguru U; Davis I; Rouse BT
    J Neurovirol; 1999 Feb; 5(1):42-7. PubMed ID: 10190689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of macrophage inflammatory protein-1alpha prevents the development of blinding herpes stromal keratitis.
    Tumpey TM; Cheng H; Cook DN; Smithies O; Oakes JE; Lausch RN
    J Virol; 1998 May; 72(5):3705-10. PubMed ID: 9557652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.
    Kintner RL; Allan RW; Brandt CR
    Arch Virol; 1995; 140(2):231-44. PubMed ID: 7710352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas.
    Drolet BS; Mott KR; Lippa AM; Wechsler SL; Perng GC
    Curr Eye Res; 2004; 29(2-3):181-9. PubMed ID: 15512965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-traumatic acquisition of herpes simplex virus infection through the eye.
    Kaye SB; Shimeld C; Grinfeld E; Maitland NJ; Hill TJ; Easty DL
    Br J Ophthalmol; 1992 Jul; 76(7):412-8. PubMed ID: 1320925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpesvirus infection of ICAM-1-deficient mice.
    Jung HW; Jung CR; Choi BK; Vinay DS; Hill JM; Gebhardt BM; Kwon BS
    Curr Eye Res; 2004; 29(2-3):201-8. PubMed ID: 15512968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP; Veress LA; Gebhardt BM; Carr DJ
    Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis.
    Wickham S; Lu B; Ash J; Carr DJ
    J Neuroimmunol; 2005 May; 162(1-2):51-9. PubMed ID: 15833359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.